EXPLORING THE EFFECTS OF DELPHINIDIN TREATMENT ON BROWNING PROCESSES IN 3T3-L1 PREADIPOCYTE CELLS: A FOODOMICS APPROACH


Demet E. D. Ö., Baş K. U., ALPASLAN A., Aslan D. T., REÇBER T., GÜLSÜN İNAL T., ...More

Farmacia, vol.74, no.1, pp.129-137, 2026 (SCI-Expanded, Scopus) identifier

  • Publication Type: Article / Article
  • Volume: 74 Issue: 1
  • Publication Date: 2026
  • Doi Number: 10.31925/farmacia.2026.1.13
  • Journal Name: Farmacia
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE
  • Page Numbers: pp.129-137
  • Keywords: adipocyte browning, delphinidin, foodomics, obesity, UCP1
  • Hacettepe University Affiliated: Yes

Abstract

Foodomics uses advanced omics technologies to evaluate the molecular effects of food components in organisms. Delphinidin, a valuable polyphenol anthocyanidin, has demonstrated protective effects against obesity-related conditions, making it a promising candidate for dietary supplements. The purpose of this study was to investigate the effects of delphinidin treatment (5, 10, and 20 µM) on 3T3-L1 preadipocytes in relation to thermogenesis and browning processes. The cells were treated in two distinct stages of adipocyte formation: during differentiation and the subsequent maturation process. To achieve this, we evaluated the expression of the main protein markers (UCP1, PGC1-α, and PPARγ) and genes correlated with browning (UCP1, PPARγ, C/EBPβ, PGC1-α, CIDEA, FABP4, and PRDM16) as well as those related to lipid metabolism. A GC-MS-based metabolomics method was used to understand delphinidin’s effects at the lipid level. The results suggest that delphinidin may contribute to the browning of adipose tissue through regulators such as UCP1 and PRDM16, while not affecting PPARγ, C/EBPβ, and FABP4. The foodomics approach, which integrates multi-omics data, indicates that delphinidin interacts across different metabolic pathways, influencing metabolites such as glyceraldehyde, alanine, and porphine. These findings offer a strong basis for the development of obesity therapeutics through dietary supplements, though further studies are required to confirm delphinidin’s browning effects.